News

ARES' Q2 earnings meet estimates as fee-related earnings and AUM grow y/y, even as revenues missed expectations.

On CoinDesk's The Policy Protocol, Renato Mariotti is joined by guest host Ari Redbord, Global Head of Policy at TRM Labs, for a conversation on the politics of the CLARITY Act, the state-vs-federal fight over prediction markets, and Wisconsin's invocation of an 1849 law that could bar prediction-market users from voting. And, they sit down with Rachel Anderica, Head of Global Operations at Anchorage Digital, who walks through Anchorage's agentic banking build inside its OCC trust and a "cashless reserves" model in partnership with JPMorgan. Plus, the hosts name the TradFi endorsers of CLARITY — BlackRock, Fidelity, and Goldman Sachs — as the Person of the Week.

Amazon's (AMZN) AWS business saw 37% revenue growth this most recent quarter. Yahoo Finance Technology Editor Dan Howley chats with Yahoo Finance Executive Editor Brian Sozzi about the results and future growth.

Apple (AAPL) stock continues to drop on Friday while shares of Amazon (AMZN) surge since the two tech giants posted earnings results yesterday. Morning Brief Host Julie Hyman is joined by Yahoo Finance Breaking News Reporter Jake Conley and Trustless Media Founder Zack Guzman take a closer look at the key figures that Apple reported in its earnings release.

Needham upgraded AXT to ‘Buy’ from ‘Hold’ with a $90 price target, implying an upside of 61% from current levels.

Rivian (NASDAQ: RIVN), the troubled EV company, went public on November 10, 2021. After a good deal of excitement, the stock is down 87% since then. Whatever hope new Q2 unit sales brought, the company is still on the ropes and is unlikely to get off them. Rivian just announced it delivered 12,194 vehicles to ... Rivian Stock Down 87% Since IPO

Reddit Inc (NYSE:RDDT) shares fell about 21% on Friday morning after management warned of volatility in search traffic and raised concerns among investors about potential pressure from artificial intelligence-powered search tools, despite reporting second quarter results that exceeded Wall...

NFL alum Christopher Halpin will take NBC’s top finance seat as it gears up for a split from its parent company Comcast.

Stocks are rallying further this morning after a solid day on Thursday. Crude oil is higher along with the dollar, while gold and silver are pulling back. Treasuries are under modest pressure.

At $585.61, Meta Platforms (NASDAQ:META) sits at a crossroads. The stock just snapped a six-quarter EPS beat streak and reset investor expectations around AI spending, making conviction in either direction premature at this price. Meta owns the largest social advertising network on the planet, monetizing 3.60 billion daily active users across Facebook, Instagram, WhatsApp, and ... What Meta Now Has to Prove Following Its Earnings Release

There is a pattern that keeps repeating in this AI earnings cycle. A company spends heavily on infrastructure. Analysts get nervous about whether the spending will ever pay off. Targets get trimmed. Then the results come in and the conversation shifts. July 29 was Microsoft's turn to go through ...

Spyglass Capital Management LLC, an investment management firm, released its second-quarter investor letter for “Spyglass Growth Strategy”. A copy of the letter can be downloaded here. Spyglass Growth Strategy appreciated 24.63% in the second quarter, significantly outperforming the Bloomberg Midcap Growth Index’s 14.05% increase, the Bloomberg 2500 Growth Index’s 19.01% gain, and the Bloomberg 500 […]

Moderna (NASDAQ:MRNA) reported second-quarter revenue of $145 million, exceeding the high end of its prior guidance range, while continuing to reduce costs and advance programs spanning respiratory vaccines, oncology and rare diseases. The company posted a net loss of $782 million, or $1.97 per sha

McDonald's heads into Q2 earnings with value meals, menu innovation and digital campaigns in focus as investors watch for sales and profit growth.

BMY highlights growth portfolio momentum, raises 2026 outlook and advances pipeline priorities as newer medicines drive results.

American Electric Power highlights rising demand, a $78B capital plan and new generation capacity as it targets long-term infrastructure growth.

AEM posts record free cash flow in Q2, advances growth projects and manages Barnat challenges while maintaining 2026 guidance.

SIMO shifts toward AI infrastructure and enterprise storage as new products, strong demand and raised outlook drive growth.

Reddit highlights AI opportunities, ad growth and product upgrades as it targets stronger user engagement and long-term growth.

Monolithic Power highlights accelerating AI infrastructure demand, capacity expansion and broader solutions as data center growth drives momentum.

MO highlights on! PLUS expansion, smoke-free growth plans and shareholder returns as it narrows 2026 earnings outlook.

First Solar highlights record backlog, U.S. manufacturing expansion, technology investments and policy-driven opportunities as demand visibility strengthens through 2030.

Coinbase highlights its push beyond crypto trading, with stablecoins, derivatives, prediction markets and agent-driven finance shaping its platform strategy.

ASE Technology expands AI semiconductor capacity as demand rises, boosting advanced packaging, testing and LEAP growth with major investment plans.

Allegro sees AI data center demand surge, with expanding design wins, backlog growth and content opportunities in electrification and automation.

SpaceX stock whipsawed through a volatile week, swinging from an all-time low to a sharp rebound and closing at a new low, as investors braced for the newly public company's first earnings report and a major share unlock.

AEE tops earnings estimates as infrastructure investments and lower fuel costs lift profit, even as revenues decline and miss expectations.

Nuclear technology and services supplier Westinghouse Electric has confidentially filed a draft registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock

The drugmaker beat second-quarter estimates on strong immunology sales but lowered its full-year adjusted earnings outlook by 14 cents a share

The stock-market selloff in July looks more like a stress test than a breaking point.